Interestingly, Zuo et al.287 revealed that aspirin was a promising drug for NPC therapy through its targeting of exosomal LMP1 (exo-LMP1) transfer and the regulatory effect of LMP1 on miR-203 expression. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.